The development of the pathophysiological concept of calciphylaxis in experiment and clinic

Pathophysiology

Volumn 7, Issue 4, 2001, Pages 231-244

  Vašků, Vladimír ^a,b   Vašků, Jaromír ^a,b  

^a VACORD Bioengineering Research Company   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Calciphylaxis; Clinical implications; Osteopontin; Pathogenesis; Prevention of calcification

Indexed keywords

BIOMATERIAL; OSTEOPONTIN;

ARTIFICIAL HEART; CALCINOSIS; CLINICAL FEATURE; COLLAGEN DISEASE; DERMATOLOGY; DIAPHRAGM; DYSTROPHY; ECTOPIC ORGAN; EXPERIMENT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; METASTASIS; MINERALIZATION; NEPHROLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGERIA; REGULATORY MECHANISM; REVIEW; SOFT TISSUE CALCIFICATION;

EID: 0035136827     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4680(00)00064-X     Document Type: Review

References (87)

1. A condition simulating human scleroderma in rats injected with parathyroid hormone
2. Calciphylaxis and the concept of vital mordanting
3. Kalziphylaxie
4. La calciphylaxie
5. Topical injury as a means of producing calcification at predetermined points with dihydrotachysterol (DHT)
6. Effect of adjuvants upon cutaneous calciphylaxis induced by topical and systemic challenge
7. On the role of adjuvants in calciphylaxis
8. Various types of calcinosis induced by egg albumen or yolk following sensitization with dihydrotachysterol (DHT)
9. Protection by calciphylaxis against an otherwise fatal parathyroid hormone intoxication
10. Production of calciphylactic facial, oesophageal and mediastinal lesions by combined treatment with dihydrotachysterol and thorium dioxide
11. Role de la réaction anaphylactoide dans un syndrome calcifiant expérimental
12. Siderocalciphylactic sensitization to mastocyte dischargers
13. Mastocalciphylaxis
14. Mast cell products and tissue calcification
15. Various forms of anaphylactoid reaction demonstrable by mastocalcergy
16. Use of relaxin in the treatment of scleroderma
17. The dermatologic implications of stress and calciphylaxis
18. An experimental model of 'dermatomyositis' induced by calciphylaxis
19. Stress and renal function in relation to the hyalinizing and calcifying lesions of connective tissue
20. Calciphylactic dermatosis produced by histamine liberators
21. Induced calcification of experimental hyalinosis
22. A calciphylactic response of the lacrimal glands to bacitracin
23. Erzeugung kalziphylaktischer Speichèl-drüsenveränderungen durch serotonin
24. The changes in the blood colloids after continuous pretreatment with horse serum and their relationship to subsequent calciphylactic reaction
25. The changes in the serum proteins, glycoproteins and lipids during the calciphylactic ferric dextran syndrome
26. On the mechanism of calciphylactic reaction
27. Die Aufgabe des Kalziums in der Pathologie des Bindegewebssystem vom Standpunkt der Kalziphylaxie
28. Comparative study of the calciphylactic challenging potency of various iron compounds
29. Calciphylactic syndrome provoked by endogenous stimulation of parathyroid glands
30. Protection by topical calciphylaxis against dihydrotachysterol intoxication
31. Kalcifylaxe a její ochranný význam (Protective effects of calciphylaxis - in Czech with Englich summary)
32. Kalcifylaxe v zánětovém vaku (Calciphylaxis in the granuloma pouch - in Czech with English summary)
33. A progeria-like syndrome produced by dihydrotachysterol and its prevention by methyltestosteron and ferric dextran
34. Stress, calciphylaxis and aging
35. Some pathophysiological aspects of the resistance of male rats to peroral daily low dihydrotachysterol doses
36. Prevention by ferric dextran of the topical calcification induced by direct calcifiers
37. Protection by various anabolic steroids against dihydrotachysterol induced calcinosis and catabolism
38. On the anticatabolic and anticalcinotic effects of 17-ethyl-19-nortestosterone
39. Effect of anabolic hormones and ferric dextran upon the progeria-like syndrome produced by dihydrotachysterol
40. Further studies on anacalciphylaxis
41. Electron microscopic study of driving diaphragms in long-term survival with a total artificial heart
42. Changes in total artificial heart driving diaphragms after long term pumping
43. 3 preincubations
44. Induction of resistance against calciphylaxis
45. Serine phosphate,threonine phosphate and gamma-carboxyglutamic acid in normal and experimentally induced pathologically calcified rat skin (topical cutaneous calciphylaxis)
46. Generalized cutaneous calcinosis and mixed connective tissue disease
47. Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure
48. Systemic calciphylaxis revisited
49. Uremic arteriopathy and ischemic skin changes (in German)
50. Epidermal and follicular calciphylaxis
51. A case of calciphylaxis. Case report
52. Calciphylaxis and systemic calcinosis. Collective review
53. Skin necrosis associated with required protein C deficiency in patients with renal failure and calciphylaxis
54. Calciphylaxis induced by iron-citrate sorbitol
55. Calciphylaxis in a hemodialysis patient: appearance after parathareoidectomy during a psoriatic flare
56. Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease
57. Calciphylaxis (in German)
58. The strenght of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix
59. Pathogenesis of calciphylaxis: study of three cases with literature review
60. Cutaneous gangrene due to hyperparathyreoidism secondary to chronic renal failure
61. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyreoidectomy
62. Severe calciphylaxis in a renal patient on long-term oral anticoagulant
63. Extensive necrotizing livedo reticularis in a patient with chronic renal disease
64. Calcifying panniculitis with renal failure: a new management approach
65. Calciphylaxis in chronic renal failure
66. Calciphylaxis with histologic changes of pseudoxanthoma elasticum
67. Proximal cutaneous calcinosis in association with chronic renal failure
68. Calciphylaxis mimicking skin lesions of connective tissue diseases
69. Calciphylaxis in patients on hemodialysis: a prevalence study
70. Editorial
71. Calciphylaxis: a cause of necrotic ulcers in renal failure
72. Calciphylaxis: pathogenesis and therapy
73. Kalcifylaxe u dlouhodobě dialysované nemocné. Article in Czech
74. Systemische Kalziphylaxie bei chronischer Niereninsuffizienz: fulminanter Verlauf nach Nierentransplantation
75. Sudden fatal pulmonary calcification following renal transplantation
76. Fulminant metastatic calcinosis with cutaneous necrosis in a child with end-stage renal disease and tertiary hyperparathyreoidism
77. Acute hyperparathyreoidism with systemic calcinosis. Report of a case
78. Calciphylaxis and cerebral atrophy in man
79. Neurotropic calcergy
80. Familial calcification of the basal ganglia with no response to parathormone